Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01120028
Previous Study | Return to List | Next Study

Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy (3C)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01120028
Recruitment Status : Unknown
Verified May 2017 by University of Oxford.
Recruitment status was:  Active, not recruiting
First Posted : May 10, 2010
Last Update Posted : November 8, 2018
Sponsor:
Collaborators:
National Health Service, United Kingdom
Pfizer
Novartis
Information provided by (Responsible Party):
University of Oxford

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Actual Primary Completion Date : February 2014
Estimated Study Completion Date : February 2019
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 June 10, 2019
August 2, 2019
2 August 19, 2019
September 19, 2019